Quick Answer
Neumora Therapeutics, Inc. reported Common Stock Shares Outstanding of 174.26 million shares for the year ending 2025.
- Neumora Therapeutics, Inc. showed an increase of +7.8% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Neumora Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 4 years of available data (2022 to 2025), Neumora Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 434.3%.
- Historical annual values: Fiscal year 2025: 174.26 million shares | Fiscal year 2024: 161.71 million shares | Fiscal year 2023: 158.83 million shares | Fiscal year 2022: 32.61 million shares.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: